Combining viral genomics and clinical data to assess risk factors for severe COVID-19 (mortality, ICU admission, or intubation) amongst hospital patients in a large acute UK NHS hospital Trust

Author:

Foxley-Marrable Max,D’Cruz LeonORCID,Meredith Paul,Glaysher Sharon,Beckett Angela H.,Goudarzi Salman,Fearn Christopher,Cook Kate F.,Loveson Katie F.,Dent Hannah,Paul Hannah,Elliott Scott,Wyllie Sarah,Lloyd Allyson,Bicknell KellyORCID,Lumley Sally,McNicholas JamesORCID,Prytherch DavidORCID,Lundgren Andrew,Graur OrORCID,Chauhan Anoop J.,Robson Samuel C.ORCID,

Abstract

Throughout the COVID-19 pandemic, valuable datasets have been collected on the effects of the virus SARS-CoV-2. In this study, we combined whole genome sequencing data with clinical data (including clinical outcomes, demographics, comorbidity, treatment information) for 929 patient cases seen at a large UK hospital Trust between March 2020 and May 2021. We identified associations between acute physiological status and three measures of disease severity; admission to the intensive care unit (ICU), requirement for intubation, and mortality. Whilst the maximum National Early Warning Score (NEWS2) was moderately associated with severe COVID-19 (A = 0.48), the admission NEWS2 was only weakly associated (A = 0.17), suggesting it is ineffective as an early predictor of severity. Patient outcome was weakly associated with myriad factors linked to acute physiological status and human genetics, including age, sex and pre-existing conditions. Overall, we found no significant links between viral genomics and severe outcomes, but saw evidence that variant subtype may impact relative risk for certain sub-populations. Specific mutations of SARS-CoV-2 appear to have little impact on overall severity risk in these data, suggesting that emerging SARS-CoV-2 variants do not result in more severe patient outcomes. However, our results show that determining a causal relationship between mutations and severe COVID-19 in the viral genome is challenging. Whilst improved understanding of the evolution of SARS-CoV-2 has been achieved through genomics, few studies on how these evolutionary changes impact on clinical outcomes have been seen due to complexities associated with data linkage. By combining viral genomics with patient records in a large acute UK hospital, this study represents a significant resource for understanding risk factors associated with COVID-19 severity. However, further understanding will likely arise from studies of the role of host genetics on disease progression.

Funder

Medical Research Council

COVID-19 Genomics UK Consortium

Department of Health and Social Care

University of Portsmouth

Wessex Academic Health Science Network

Research England

Science and Technology Facilities Council

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference76 articles.

1. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges;CC Lai;International Journal of Antimicrobial Agents,2020

2. In Hunt for Covid-19 Origin, Patient Zero Points to Second Wuhan Market;J Page;The Wall Street Journal,2021

3. COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. [cited 2022 May 25]. Available from: https://coronavirus.jhu.edu/map.html.

4. Long COVID or Post-COVID Conditions;CDC;Centers for Disease Control and Prevention,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3